Burden of illness of follicular lymphoma and marginal zone lymphoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Burden of illness of follicular lymphoma and marginal zone lymphoma
Authors
Keywords
MZL, FL, Epidemiology, Costs, Economics, QoL
Journal
ANNALS OF HEMATOLOGY
Volume 98, Issue 1, Pages 175-183
Publisher
Springer Nature
Online
2018-10-13
DOI
10.1007/s00277-018-3501-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States
- (2016) Chadi Nabhan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
- (2016) Matthew J. Maurer et al. AMERICAN JOURNAL OF HEMATOLOGY
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging therapies for the treatment of relapsed or refractory follicular lymphoma
- (2016) D. MacDonald et al. Current Oncology
- Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database
- (2016) Vít Procházka et al. LEUKEMIA & LYMPHOMA
- Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data
- (2016) Mark D. Danese et al. MEDICAL CARE
- Cancer incidence in France over the 1980–2012 period: Hematological malignancies
- (2016) S. Le Guyader-Peyrou et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Gastrointestinal follicular lymphoma: using primary site as a predictor of survival
- (2016) Jay Chouhan et al. Cancer Medicine
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Life expectancy of young adults with follicular lymphoma
- (2015) A. Conconi et al. ANNALS OF ONCOLOGY
- Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network
- (2015) A Smith et al. BRITISH JOURNAL OF CANCER
- Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
- (2015) Chadi Nabhan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults
- (2015) Shane A. Gangatharan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis
- (2015) Yazan Migdady et al. LEUKEMIA & LYMPHOMA
- Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site
- (2014) Mohammad O. Khalil et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry
- (2014) Simone Oerlemans et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Trends in excess mortality in follicular lymphoma at a population level
- (2014) Morgane Mounier et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006
- (2014) Marina T. van Leeuwen et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group
- (2014) Yasuo Hirayama et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
- (2013) Adam J. Olszewski et al. ANNALS OF HEMATOLOGY
- Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database
- (2013) A. J. Olszewski et al. ANNALS OF ONCOLOGY
- ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
- (2013) M. Dreyling et al. ANNALS OF ONCOLOGY
- Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
- (2013) D. Tan et al. BLOOD
- Differences in incidence and trends of haematological malignancies in Japan and the United States
- (2013) Dai Chihara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands
- (2013) S. A. M. van de Schans et al. HAEMATOLOGICA
- Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients
- (2013) Octavio Servitje et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites
- (2013) Marion J. J. Kuper-Hommel et al. LEUKEMIA & LYMPHOMA
- Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment
- (2013) Julien Lenglet et al. LEUKEMIA & LYMPHOMA
- Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study
- (2013) Trine Allerslev Horsboel et al. Journal of Cancer Survivorship
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
- (2012) M. Ghielmini et al. ANNALS OF ONCOLOGY
- Survival of patients with marginal zone lymphoma
- (2012) Adam J. Olszewski et al. CANCER
- Early stage follicular lymphoma, current management and controversies
- (2012) Caron A. Jacobson et al. CURRENT OPINION IN ONCOLOGY
- Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France
- (2012) Alain Monnereau et al. INTERNATIONAL JOURNAL OF CANCER
- Splenic marginal zone lymphoma: a population-based study on the 2001–2008 incidence and survival in the United States
- (2012) Lihua Liu et al. LEUKEMIA & LYMPHOMA
- Expected long-term survival of older patients diagnosed with non-Hodgkin lymphoma in 2008–2012
- (2011) Dianne Pulte et al. Cancer Epidemiology
- Long-term clinical outcome of gastric MALT lymphoma after eradication ofHelicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan
- (2011) Shotaro Nakamura et al. GUT
- Economic impact of disease progression in follicular non-Hodgkin lymphoma
- (2011) Roy Beveridge et al. LEUKEMIA & LYMPHOMA
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
- (2010) Gilles Salles et al. LANCET
- Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
- (2009) A. Stathis et al. ANNALS OF ONCOLOGY
- Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas
- (2009) S. Luminari et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started